1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Upper Limb Muscle Spasticity Global Clinical Trials Review, H2, 2016

Upper Limb Muscle Spasticity Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Upper Limb Muscle Spasticity Global Clinical Trials Review, H2, 2016" provides an overview of Upper Limb Muscle Spasticity clinical trials scenario. This report provides top line data relating to the clinical trials on Upper Limb Muscle Spasticity. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Upper Limb Muscle Spasticity Global Clinical Trials Review, H2, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Upper Limb Muscle Spasticity to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Upper Limb Muscle Spasticity to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Upper Limb Muscle Spasticity Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Upper Limb Muscle Spasticity 30
Sep 15, 2016: Ipsen Biopharmaceuticals Announces Eight Presentations for Dysport (abobotulinumtoxinA) at the Annual Meeting of the American Association of Neuromuscular and Electrodiagnostic Medicine 30
Clinical Trial Profile Snapshots 31
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 60

List of Tables
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials by Region, 2016* 6
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
Proportion of Upper Limb Muscle Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14
Upper Limb Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Upper Limb Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Upper Limb Muscle Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17
Upper Limb Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Upper Limb Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Upper Limb Muscle Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 13
Proportion of Upper Limb Muscle Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14
Upper Limb Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Upper Limb Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Upper Limb Muscle Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17
Upper Limb Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Upper Limb Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Upper Limb Muscle Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Upper Limb Muscle Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Upper Limb Muscle Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
GlobalData Methodology 58

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Radiopharmaceutical Market, Nephrology, Neurology, and Immunology - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Radiopharmaceutical Market, Nephrology, Neurology, and Immunology - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5595
  • Industry report
  • October 2016
  • by Transparency Market Research

Radiopharmaceutical Market: Scope and Trends This report on the radiopharmaceutical market analyzes the current and future scenario of the global market. Increase in incidence of various diseases, development ...

Refurbished Medical Equipment Market: By Type (Medical Imaging, Operating Room & Surgical, Patient Monitors, Cardiovascular & Cardiology, Defibrillators, Neurology, Others) & By Region-Forecast (2016-2021)

Refurbished Medical Equipment Market: By Type (Medical Imaging, Operating Room & Surgical, Patient Monitors, Cardiovascular & Cardiology, Defibrillators, Neurology, Others) & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Refurbished medical equipment market is being primarily driven by factors like development of e-commerce platform enhancing the ease of purchase of refurbished medical equipment, growing demand for refurbished ...

Epilepsy  - Market Insights, Epidemiology and Market Forecast-2023

Epilepsy  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Epilepsy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.